SCHEMBL22839951

SCHEMBL22839951

CNc1c(O)ccc(CCN(Cc2ccc(C=O)cc2F)C(=O)OC(C)(C)C)c1/C=C\C=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.31
▸ SSTR4 P31391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22839880 0.87 — —
SCHEMBL22839937 0.84 NAMPT (0.33) NAMPT
SCHEMBL22839893 0.84 SSTR4 (0.32) SSTR4
SCHEMBL22839890 0.83 PTGDR2 (0.31) —
SCHEMBL22839942 0.82 EPHX2 (0.33) —
SCHEMBL22839885 0.82 P4HB (0.32) —
SCHEMBL22839818 0.81 EPHX2 (0.34) —
SCHEMBL22839886 0.81 SSTR4 (0.30) SSTR4
SCHEMBL22839795 0.81 — —
SCHEMBL22839884 0.81 HTT (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP disclosed
Send feedback